We are international
Donate
TEXT SIZE   


Phase I/II THALOMID® Clinical Trials
05.01.08

US TRIALS

  • Tandem High-Dose Therapy With Melphalan & Total Marrow Irradiation (TMI) With PBPC Support & Dexamethasone/Thalidomide Maintenance (CHNMC-04064)
    Duarte, CA

  • Phase I/II Combination Immunotherapy After ASCT for Advanced Myeloma to Study HTERT Vaccination Followed by Adoptive Transfer of Vaccine-Primed Autologous T Cells (MSGCC-0610-GCC)
    multicenter

FOREIGN TRIALS

  • A Phase I/II, Multi-Center, Open Label Study of Melphalan, Prednisone, Thalidomide and Defibrotide in Advanced and Refractory Multiple Myeloma Patients (MM2005)
    Italy - multicenter


 related articles